| abstract |
A transdermal therapeutic system with an inert back layer matrix ingredient, a (-) - 5,6,7,8-tetrahydro-6- [propyl [2- (2-thienyl) ethyl] amino] -1-naphthol in effect the amount of exhibiting self-adhesive matrix layer and a protective film to be removed prior to use is characterized by a matrix based on an aqueous polymeric adhesive system on acrylate and silicone, respectively, having a solubility of (-) - 5,6,7,8-tetrahydro-soluble. 6- [propyl [2- (2-thienyl) ethyl] amino] -1-naphthol of> 5% (g / g) which is essentially free of inorganic silicate particles. |